EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Risk of Achilles tendon rupture following single-dose ciprofloxacin use in transrectal prostate biopsies

Michaela Runnaes, Erik Lampa, Johan Styrke, Karl-Johan Lundström

Scandinavian Journal of Urology · 16.04.2026 · 61 · 121-126

DOI: 10.2340/sju.v61.45649 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scandinavian Journal of Urology, online erschienen am 16.04.2026. Verfasst von Michaela Runnaes und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostics and Intervention, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: Ciprofloxacin, Achilles Tendon, Prostate, Anti-Bacterial Agents. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To assess the risk of Achilles tendon rupture (ATR) following single-dose ciprofloxacin prophylaxis for transrectal prostate biopsy.

Methods

Using the Prostate Cancer data Base Sweden (PCBaSe 5.0), we analysed 44,959 prostate biopsy exposures versus 662,520 non-exposures to assess the risk of ATR. Prostate biopsy served as a proxy for quinolone use, with single-dose ciprofloxacin being the recommended and most extensively documented prophylaxis in Sweden for this procedure. The outcome was ATR in men who underwent a biopsy compared to those who did not.

Results

The incidence rate of ATR was 60.46 per 100,000 person-years in the no-biopsy group, compared to 62,77 per 100,000 person-years in the biopsy group. The multivariable analysis yielded a hazard ratio of 0.98 (95% confidence interval [CI]: 0.83–1.15).

Conclusions

Transrectal prostate biopsy was not associated with an elevated risk of Achilles tendon rupture. This provides some evidence against single-dose ciprofloxacin being a relevant risk factor for this outcome, but there is remaining uncertainty related to study limitations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CiprofloxacinAchilles TendonProstateAnti-Bacterial AgentsProstatic NeoplasmsAntibiotic ProphylaxisTendon InjuriesHumansMaleRuptureAgedMiddle AgedSwedenBiopsyRisk FactorsIncidence

Substanzen

CiprofloxacinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Diagnostics and Intervention, Umeå University, Umeå, Sweden.
  • Epistat AB, Uppsala, Sweden.
  • Department of Diagnostics and Intervention, Umeå University, Umeå, Sweden. karl-johan.lundstrom@umu.se.

Zitieren

APA

Runnaes, M., Lampa, E., Styrke, J., & Lundström, K. J. (2026). Risk of Achilles tendon rupture following single-dose ciprofloxacin use in transrectal prostate biopsies. Scandinavian Journal of Urology, 61, 121-126. https://doi.org/10.2340/sju.v61.45649

Vancouver

Runnaes M, Lampa E, Styrke J, Lundström KJ. Risk of Achilles tendon rupture following single-dose ciprofloxacin use in transrectal prostate biopsies. Scandinavian Journal of Urology. 2026;61:121-126. doi:10.2340/sju.v61.45649

BibTeX
@article{Runnaes2026,
  author = {Runnaes, Michaela and Lampa, Erik and Styrke, Johan and Lundström, Karl-Johan},
  title = {Risk of Achilles tendon rupture following single-dose ciprofloxacin use in transrectal prostate biopsies},
  journal = {Scandinavian Journal of Urology},
  year = {2026},
  volume = {61},
  pages = {121--126},
  doi = {10.2340/sju.v61.45649}
}
Kostenlos starten →